FUDZS

WHY THIS PROJECT ?

Harnessing cellular bioproduction at scale can indeed enable a future sustainable bioeconomy, and Fudzs is at the forefront of this transformation. By merging advanced biomaterial engineering with cutting-edge cellular science and bioreactor technology, Fudzs is leading the way in revolutionizing how we produce vaccines, cell therapies, regenerative medicine, and cultivated proteins. These industries face critical challenges in sustainability, efficiency, and cost-effectiveness, and Fudzs’s innovative approach directly addresses these concerns.

THE MISSION

FUDZS is committed to revolutionizing bioproduction by developing cutting-edge, sustainable, and cost-effective cell manufacturing processes. The company's mission is threefold:

-Environmental Responsibility: Reducing the ecological footprint of traditional production methods through innovative biotechnological approaches.

-Public Health Advancement: Providing safe, bio-based solutions for cultivated food, regenerative medicine, and therapeutic applications.

-Industrial Sovereignty: Strengthening the independence of industries by making bio-based production more accessible and scalable.

By integrating expertise from biomaterial engineering, cellular science, and process automation, FUDZS aims to shape the future of sustainable bioeconomy.

 A DISRUPTIVE INNOVATION

FUDZS's core innovation lies in its highly scalable and cost-effective bioproduction platform. This breakthrough enables the mass production of cells at an unprecedented low cost, unlocking new commercial opportunities in industries such as cultivated meat, tissue engineering, and biopharmaceuticals.

Unlike conventional methods that struggle with cost and efficiency, FUDZS leverages state-of-the-art bioreactor technology and advanced process optimization. This allows for the large-scale cultivation of cells while maintaining product quality, reducing resource consumption, and improving affordability.

POSITIVE IMPACT ON THE SOCIETY

Fudzs aims to make a positive societal impact in several ways:

• SDG 2: Zero Hunger
  Fudzs aims to contribute to global food security by making their solutions affordable and accessible. Their bioreactor technology, optimized for high-density cell culture, maximizes yield while minimizing operational costs, which is essential for achieving this goal. Large-scale cell production at unbeatable costs is central to their vision.

• SDG 3: Good Health and Well-being
  Fudzs seeks to offer healthier products produced in controlled conditions, reducing contamination risks. Their next-generation bioproduction platform incorporates smart process automation, with AI-driven monitoring and optimization to ensure efficiency and consistency. This contributes to providing safe, sustainable biosourced products for public health.

• SDG 12: Responsible Consumption and Production
  Fudzs is committed to reducing the environmental impact of production by cutting CO2 emissions, land use, and water consumption. The company promotes local production through small facilities connected to local markets, minimizing waste and long-distance transportation. Their goal is to make sustainable and ethical products commercially viable, thus reducing the overall environmental footprint.

• SDG 13: Climate Action
  By reducing CO2 emissions from production, Fudzs contributes to the fight against climate change.

• SDG 15: Life on Land
  Fudzs aims to protect biodiversity by promoting a sustainable alternative to intensive farming practices, which contribute to deforestation and habitat loss. The startup also plans to collaborate with farmers to guide them toward more sustainable farming models. Their vision aligns with the development of a bioeconomy that is environmentally respectful.

LEVERAGING THE 3DEXPERIENCE PLATFORM

-Fudzs plans to leverage Dassault Systèmes' 3DEXPERIENCE platform to create a digital twin of their bioreactor.

-This will enable the simulation and optimization of physical and biochemical conditions of the production process.

-They also plan to design a virtual factory connected to the real facility to streamline operations, maintenance, training, and daily activities.

-Their next-generation bioproduction platform integrates advanced bioreactor technology optimized for high-density cell culture.

COLLABORATIVE AND COLLECTIVE INTELLIGENCE

-The founding team has diverse backgrounds (biology, finance, data science), fostering a multidisciplinary approach.

-They plan to recruit additional experts in biology and production.

-Fudzs is in discussions with companies and experts in the sector.

-CEO & CSO, Zied Souguir, has experience in the biopharmaceutical sector, reflecting strong ties to scientific research.

-The Fudzs team combines over 50 years of expertise in fields like chemistry, biology, artificial intelligence, and marketing.

-They are also seeking strategic partnerships to support their innovation.